One-year outcome of percutaneous mitral valve repair in patients with severe symptomatic mitral valve regurgitation

Figure 1 Changes in mitral regurgitation and New York Heart Association functional class. A: Degree of mitral regurgitation before and after percutaneous mitral valve repair with the MitraClip^® system in all study patients (n = 46); B: NYHA functional classes before and after percutaneous mitral valve repair with the MitraClip^® system in all study patients (n = 46). NYHA: New York Heart Association functional class.

Figure 2 All-cause mortality and B-type natriuretic peptide. A: Kaplan-Meier estimates of freedom from all-cause mortality; B: Kaplan-Meier estimates of freedom from all-cause mortality according to low pre-procedural BNP levels (BNP ≤ 817 pg/mL) and high pre-procedural BNP levels (BNP > 817 pg/mL). BNP: B-type natriuretic peptide.